{
  "meta": {
    "title": "73_Scleroderma_Sjogrens_Syndrome",
    "url": "https://brainandscalpel.vercel.app/73-scleroderma-sjogrens-syndrome-206a035b.html",
    "scrapedAt": "2025-11-30T06:57:38.699Z"
  },
  "questions": [
    {
      "id": 62834,
      "choices": [
        {
          "id": 233974,
          "text": "SLE"
        },
        {
          "id": 233975,
          "text": "Localized SSc"
        },
        {
          "id": 233976,
          "text": "Diffuse SSc"
        },
        {
          "id": 233977,
          "text": "PAN"
        }
      ],
      "text": "A 44-year-old lady presents to the clinic with shortening of the digits in her hands. She has an history of pallor of extremities followed by pain and cyanosison exposure to cold during her adolescence. 6months back she had noticed puffiness of her fingers and face. ANA was positive with Nucleolar pattern of immunofluorescence. What is the likely diagnosis.",
      "unique_key": "Q9441662",
      "question_audio": null,
      "question_video": null,
      "map_id": 34765082,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Diffuse Systemic Sclerosis (SSc). Diffuse systemic sclerosis is an autoimmune connective tissue disease characterized by widespread fibrosis, vascular abnormalities, and immune system activation. This patient presents with classic features of diffuse SSc, including shortening of digits (sclerodactyly), Raynaud’s phenomenon (pallor, pain, cyanosis on cold exposure), puffiness of fingers and face (edema preceding skin thickening), and a positive ANA with a nucleolar pattern, which is strongly associated with systemic sclerosis. The diffuse subtype involves widespread skin and internal organ involvement, making it the most likely diagnosis given the constellation of findings. Why the Other Options Are Incorrect: A) SLE (Systemic Lupus Erythematosus): While SLE can present with Raynaud’s phenomenon and a positive ANA, it does not typically cause sclerodactyly or shortening of digits. The puffiness of the face and fingers and the nucleolar ANA pattern are not characteristic of SLE. Additionally, SLE does not commonly result in the extensive fibrosis seen in systemic sclerosis. B) Localized SSc: Localized systemic sclerosis, such as morphea or linear scleroderma, is confined to limited skin areas and does not involve systemic features like Raynaud’s phenomenon or widespread skin tightening. The presence of diffuse skin involvement and systemic symptoms in this patient excludes localized SSc. D) PAN (Polyarteritis Nodosa): Polyarteritis nodosa is a systemic necrotizing vasculitis that affects medium-sized arteries. While it can cause systemic symptoms, Raynaud’s phenomenon, sclerodactyly, and a positive ANA are not features of PAN. The absence of other vasculitic symptoms such as livedo reticularis, hypertension, or mononeuritis multiplex makes PAN unlikely.",
      "correct_choice_id": 233976,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42527931698838626/42527931698838626.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42527931698838626/42527931698838626.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62835,
      "choices": [
        {
          "id": 233978,
          "text": "Vasospasm of arteries"
        },
        {
          "id": 233979,
          "text": "Diffuse microangiopathy"
        },
        {
          "id": 233980,
          "text": "Autoimmunity"
        },
        {
          "id": 233981,
          "text": "Visceral fibrosis"
        }
      ],
      "text": "Systemic sclerosis is characterized by following cardinal pathophysiological processes EXCEPT:",
      "unique_key": "Q3515443",
      "question_audio": null,
      "question_video": null,
      "map_id": 34550749,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Vasospasm of arteries. While vasospasm, such as that seen in Raynaud’s phenomenon, is a common feature in systemic sclerosis, it is not a cardinal pathophysiological process underlying the disease itself. Raynaud's phenomenon is a clinical manifestation resulting from vascular dysfunction but not a direct part of the core pathological mechanisms. The fundamental processes in systemic sclerosis include diffuse microangiopathy, autoimmunity, and visceral fibrosis, which collectively drive the disease's progression and manifestations. Why the Other Options Are Correct: B) Diffuse Microangiopathy: Diffuse microangiopathy is a hallmark of systemic sclerosis and plays a central role in its pathogenesis. It involves structural damage to small blood vessels, leading to reduced perfusion, ischemia, and tissue damage. This process contributes to Raynaud’s phenomenon, digital ulcers, and organ damage. C) Autoimmunity: Autoimmunity is a key driver of systemic sclerosis. The disease is associated with autoantibodies (e.g., anti-centromere and anti-Scl-70), which contribute to immune-mediated inflammation, fibroblast activation, and tissue damage. Immune dysregulation plays a significant role in both the vascular and fibrotic components of the disease. D) Visceral Fibrosis: Visceral fibrosis, resulting from excessive collagen deposition, is a defining characteristic of systemic sclerosis. This leads to progressive damage to internal organs such as the lungs (interstitial lung disease), heart (myocardial fibrosis), gastrointestinal tract, and kidneys. Fibrosis underpins the morbidity and mortality associated with systemic sclerosis. Why the Correct Answer Is Incorrect: A) Vasospasm of arteries: Vasospasm, while prominent in conditions like Raynaud’s phenomenon, is a secondary phenomenon in systemic sclerosis and not a cardinal pathophysiological process. It results from the underlying vascular dysfunction and is not central to the disease's pathogenesis. Instead, microangiopathy and structural vascular damage are the primary mechanisms responsible for the vascular manifestations of systemic sclerosis.",
      "correct_choice_id": 233978,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/65723111698838656/65723111698838656.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/65723111698838656/65723111698838656.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62836,
      "choices": [
        {
          "id": 233982,
          "text": "PAH"
        },
        {
          "id": 233983,
          "text": "Renal crisis"
        },
        {
          "id": 233984,
          "text": "Cardiac complications"
        },
        {
          "id": 233985,
          "text": "ILD"
        }
      ],
      "text": "The most common cause of death in systemic sclerosis is:",
      "unique_key": "Q1999189",
      "question_audio": null,
      "question_video": null,
      "map_id": 34558353,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Pulmonary Arterial Hypertension (PAH). Pulmonary arterial hypertension (PAH) is the most common cause of death in systemic sclerosis, particularly in patients with limited cutaneous systemic sclerosis. PAH results from progressive vascular damage, including endothelial dysfunction and intimal hyperplasia in the pulmonary arteries, leading to increased pulmonary vascular resistance and, ultimately, right heart failure. PAH is often insidious in onset, making early detection critical. It significantly contributes to morbidity and mortality in systemic sclerosis, especially when untreated or diagnosed late. Why the Other Options Are Incorrect: B) Renal Crisis: Renal crisis, characterized by severe hypertension and acute renal failure, was historically a leading cause of death in systemic sclerosis. However, the introduction of ACE inhibitors has dramatically improved outcomes in these patients. While it remains a serious complication, its contribution to mortality has decreased with modern therapeutic management. C) Cardiac Complications: Cardiac involvement in systemic sclerosis, such as myocardial fibrosis, arrhythmias, and heart failure, is a significant contributor to morbidity and mortality. However, cardiac complications are less common as the primary cause of death compared to PAH or interstitial lung disease. They often occur secondary to pulmonary or renal involvement. D) Interstitial Lung Disease (ILD): Interstitial lung disease is a major cause of mortality in patients with diffuse systemic sclerosis, resulting from progressive pulmonary fibrosis and respiratory failure. While ILD is a significant contributor to mortality, PAH remains the most common overall cause of death in systemic sclerosis, especially in limited cutaneous disease.",
      "correct_choice_id": 233982,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/37650121698838669/37650121698838669.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/37650121698838669/37650121698838669.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62837,
      "choices": [
        {
          "id": 233986,
          "text": "EBV"
        },
        {
          "id": 233987,
          "text": "CMV"
        },
        {
          "id": 233988,
          "text": "Mycoplasma"
        },
        {
          "id": 233989,
          "text": "Klebsiella"
        }
      ],
      "text": "Suspected microorganism in etio- pathogenesis of systemic sclerosis is",
      "unique_key": "Q9551371",
      "question_audio": null,
      "question_video": null,
      "map_id": 34716059,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) CMV (Cytomegalovirus). Cytomegalovirus (CMV) has been implicated in the pathogenesis of systemic sclerosis (SSc) due to its potential role in immune modulation and fibrosis. CMV infection has been shown to contribute to immune dysregulation and may activate pathways involved in tissue fibrosis, which is a hallmark of systemic sclerosis. The virus might trigger or exacerbate the disease through immune activation and chronic inflammation, potentially influencing the fibroblast activation that drives fibrosis in systemic sclerosis. This association with CMV is still being investigated, but it is one of the viruses suspected in the disease’s etiology. Why the Other Options Are Incorrect: A) EBV (Epstein-Barr Virus): While Epstein-Barr virus (EBV) has been linked to various autoimmune diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis, its role in systemic sclerosis is less well-defined. EBV infection may contribute to immune dysregulation in some patients, but it is not considered a major factor in the etiology of systemic sclerosis as CMV is. C) Mycoplasma: Mycoplasma infections are not strongly associated with systemic sclerosis. Though mycoplasma can trigger other autoimmune conditions (such as reactive arthritis), there is no direct, well-established link between mycoplasma infection and the pathogenesis of systemic sclerosis. D) Klebsiella: Klebsiella is a bacterium that has been suggested in some studies to be associated with reactive arthritis or ankylosing spondylitis, particularly in those with HLA-B27. However, Klebsiella has not been implicated in the pathogenesis of systemic sclerosis, and its role in autoimmune diseases like systemic sclerosis remains unsubstantiated.",
      "correct_choice_id": 233987,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/57051111698838696/57051111698838696.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/57051111698838696/57051111698838696.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62838,
      "choices": [
        {
          "id": 233990,
          "text": "Skin involvement"
        },
        {
          "id": 233991,
          "text": "Pulmonary fibrosis"
        },
        {
          "id": 233992,
          "text": "pulmonary artery HT"
        },
        {
          "id": 233993,
          "text": "oesophageal dysmotility"
        }
      ],
      "text": "Which manifestation is more common in limited systemic sclerosis as compared with diffuse Ssc?",
      "unique_key": "Q6361878",
      "question_audio": null,
      "question_video": null,
      "map_id": 34065278,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Oesophageal Dysmotility. Oesophageal dysmotility is more commonly seen in limited systemic sclerosis (SSc) compared to diffuse systemic sclerosis. In limited SSc, the disease often affects the gastrointestinal tract, particularly the esophagus, leading to motility disorders such as dysphagia (difficulty swallowing) and gastroesophageal reflux. This is primarily due to fibrosis and loss of smooth muscle function in the esophagus, resulting in impaired peristalsis. The involvement is often more prominent in limited SSc, where the skin changes are confined to the distal extremities and face, and internal organ involvement tends to be less severe than in diffuse SSc. Why the Other Options Are Incorrect: A) Skin Involvement: In diffuse systemic sclerosis, skin involvement is more extensive and widespread compared to limited SSc. Diffuse SSc causes more rapid skin thickening, often involving the trunk and proximal extremities, whereas limited SSc primarily affects the skin of the fingers, forearms, and face. Skin involvement is, therefore, more prominent in diffuse SSc. B) Pulmonary Fibrosis: Pulmonary fibrosis is more common in diffuse systemic sclerosis than in limited SSc. Diffuse SSc is associated with more extensive internal organ involvement, including the lungs, where fibrosis can lead to interstitial lung disease. In contrast, pulmonary fibrosis is generally less severe and less frequent in limited SSc. C) Pulmonary Artery Hypertension (PAH): Pulmonary arterial hypertension (PAH) is more commonly seen in limited SSc than in diffuse SSc. In limited SSc, PAH can develop due to the vascular abnormalities associated with the disease, particularly in the setting of Raynaud’s phenomenon and vascular damage. PAH is a significant cause of morbidity and mortality in limited SSc but less so in diffuse SSc, where more severe internal organ involvement (e.g., interstitial lung disease) is usually more concerning.",
      "correct_choice_id": 233993,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/17772471698838720/17772471698838720.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/17772471698838720/17772471698838720.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62839,
      "choices": [
        {
          "id": 233994,
          "text": "Microstomia is only seen in diffuse cutaneous systemic sclerosis"
        },
        {
          "id": 233995,
          "text": "Skin involvement is restricted to face, hands (distal to elbow) in limited systemic sclerosis"
        },
        {
          "id": 233996,
          "text": "Anti-dsDNA are normally detected"
        },
        {
          "id": 233997,
          "text": "Raynaud’s occurs due to skin sclerosis"
        }
      ],
      "text": "A 42-year-old woman presents with retrosternal discomfort. She was diagnosed with systemic sclerosis one year back. Which of the following statements is true about systemic sclerosis?",
      "unique_key": "Q5921981",
      "question_audio": null,
      "question_video": null,
      "map_id": 34252025,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Skin involvement is restricted to face, hands (distal to elbow) in limited systemic sclerosis. In limited systemic sclerosis, skin involvement is typically restricted to the face, fingers, and forearms (distal to the elbows), often in a more localized and less extensive pattern compared to diffuse systemic sclerosis. The hallmark of limited SSc is the slow progression of skin changes that predominantly affect the distal extremities and face, with telangiectasias and calcinosis often being seen. This type of systemic sclerosis also has a higher association with pulmonary arterial hypertension (PAH) and Raynaud’s phenomenon. The skin involvement in limited SSc is typically more benign compared to the widespread fibrosis seen in diffuse SSc. Why the Other Options Are Incorrect: A) Microstomia is only seen in diffuse cutaneous systemic sclerosis: Microstomia (small mouth) is actually more commonly seen in diffuse cutaneous systemic sclerosis, not limited SSc. In diffuse SSc, the skin thickening extends to the face, including the perioral area, leading to restricted mouth opening. This can cause significant difficulty with eating and oral hygiene. In limited SSc, the skin involvement does not usually extend to the perioral area, so microstomia is less common. C) Anti-dsDNA are normally detected: Anti-dsDNA antibodies are typically associated with systemic lupus erythematosus (SLE), not systemic sclerosis. In systemic sclerosis, the most common autoantibodies are anti-centromere antibodies (in limited SSc) and anti-Scl-70 antibodies (in diffuse SSc), which are specific to the disease. Therefore, the presence of anti-dsDNA is not typical in systemic sclerosis. D) Raynaud’s occurs due to skin sclerosis: Raynaud’s phenomenon in systemic sclerosis is primarily due to vascular abnormalities rather than skin sclerosis itself. It results from endothelial dysfunction and vascular spasm in response to cold or stress, leading to reduced blood flow to the extremities, causing color changes in the fingers and toes. While skin sclerosis can contribute to vascular changes by restricting blood flow, Raynaud’s is not caused by skin thickening directly, but rather by vascular involvement seen in both diffuse and limited forms of systemic sclerosis.",
      "correct_choice_id": 233995,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7961641698838748/7961641698838748.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7961641698838748/7961641698838748.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62840,
      "choices": [
        {
          "id": 233998,
          "text": "Raynaud’s phenomenon is seen years before skin changes"
        },
        {
          "id": 233999,
          "text": "Trunk involvement"
        },
        {
          "id": 234000,
          "text": "Anti-centromere antibodies are characteristic"
        },
        {
          "id": 234001,
          "text": "Frequent systemic complains"
        }
      ],
      "text": "All of the following about Diffuse SSc are true except:",
      "unique_key": "Q4156619",
      "question_audio": null,
      "question_video": null,
      "map_id": 34648366,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Anti-centromere antibodies are characteristic. Anti-centromere antibodies are characteristic of limited systemic sclerosis (SSc), not diffuse SSc. In diffuse SSc, anti-Scl-70 antibodies (also known as anti-topoisomerase I antibodies) are more commonly detected. These antibodies are associated with more extensive skin involvement and a higher risk of interstitial lung disease. In contrast, anti-centromere antibodies are typically found in limited cutaneous systemic sclerosis and are linked with a higher risk of pulmonary arterial hypertension (PAH) rather than the more extensive fibrosis seen in diffuse SSc. Why the Other Options Are Correct: A) Raynaud’s phenomenon is seen years before skin changes: Raynaud's phenomenon is often one of the earliest clinical signs of systemic sclerosis, particularly in diffuse SSc. It can appear years before the skin thickening (sclerosis) begins. Raynaud's phenomenon is a result of vascular abnormalities such as vasospasm and endothelial dysfunction, which are common in SSc. These vascular changes occur early in the disease, even before the hallmark skin changes. B) Trunk involvement: In diffuse systemic sclerosis, skin thickening commonly involves the trunk, in addition to the face and proximal limbs. This is in contrast to limited SSc, where the skin involvement is typically restricted to the distal extremities and face. Trunk involvement is a feature of diffuse SSc and reflects the more widespread and aggressive nature of the disease in this subtype. D) Frequent systemic complaints: Diffuse SSc is associated with frequent systemic complaints, including symptoms such as fatigue, weight loss, joint pain, and gastrointestinal issues (e.g., dysphagia, reflux). The systemic nature of diffuse SSc involves multiple organ systems, including the heart, lungs, kidneys, and gastrointestinal tract, leading to significant morbidity. This makes systemic complaints more common in diffuse SSc compared to the more limited manifestations of limited SSc.",
      "correct_choice_id": 234000,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75107821698838778/75107821698838778.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75107821698838778/75107821698838778.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62841,
      "choices": [
        {
          "id": 234002,
          "text": "Neoplasm"
        },
        {
          "id": 234003,
          "text": "Primary biliary cirrhosis"
        },
        {
          "id": 234004,
          "text": "Rheumatoid arthritis"
        },
        {
          "id": 234005,
          "text": "Systemic sclerosis"
        }
      ],
      "text": "Secondary Sicca syndrome is associated with all except:",
      "unique_key": "Q1645577",
      "question_audio": null,
      "question_video": null,
      "map_id": 34380432,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Neoplasm. Secondary Sicca syndrome is a condition where the dryness of the eyes (keratoconjunctivitis sicca) and mouth (xerostomia) occurs as a result of another underlying condition. Neoplasm is not typically associated with secondary Sicca syndrome. While some cancers may cause symptoms that resemble those of Sicca syndrome (e.g., salivary gland involvement in head and neck cancers), neoplasms themselves are not a recognized cause of secondary Sicca syndrome. Secondary Sicca syndrome is most commonly linked to autoimmune and inflammatory diseases, rather than cancer. Why the Other Options Are Correct: B) Primary Biliary Cirrhosis: Primary biliary cirrhosis (also known as primary biliary cholangitis) is an autoimmune disease that can lead to secondary Sicca syndrome. This condition is associated with chronic inflammation of the bile ducts and can overlap with other autoimmune diseases, including those that cause dryness of the eyes and mouth, such as Sjögren's syndrome. C) Rheumatoid Arthritis: Rheumatoid arthritis (RA) is one of the most common conditions associated with secondary Sicca syndrome. RA is an autoimmune disease that can affect the salivary and lacrimal glands, leading to dryness of the eyes and mouth. This overlap occurs because of the shared autoimmune mechanisms between RA and conditions like Sjögren’s syndrome, which directly causes Sicca symptoms. D) Systemic Sclerosis: Systemic sclerosis (also known as scleroderma) is another condition that is commonly associated with secondary Sicca syndrome. It is an autoimmune disorder that causes fibrosis of the skin and internal organs, and it can also affect the salivary and lacrimal glands, leading to dryness of the eyes and mouth. The overlap between systemic sclerosis and Sicca symptoms is due to autoimmune and inflammatory processes.",
      "correct_choice_id": 234002,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/35069511698838856/35069511698838856.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/35069511698838856/35069511698838856.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62842,
      "choices": [
        {
          "id": 234006,
          "text": "Primary Sjogren’s is associated with increased risk of systemic manifestations"
        },
        {
          "id": 234007,
          "text": "secondary Sjogren’s has increased risk of lymphoma"
        },
        {
          "id": 234008,
          "text": "Elderly onset of disease has poorer prognosis"
        },
        {
          "id": 234009,
          "text": "High SSA antibody titers is associated with increased risk of lymphoma"
        }
      ],
      "text": "The following statements are true regarding Sjogren’s syndrome EXCEPT:",
      "unique_key": "Q2970814",
      "question_audio": null,
      "question_video": null,
      "map_id": 34005615,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Secondary Sjogren’s has increased risk of lymphoma. While secondary Sjogren's syndrome can be associated with an increased risk of lymphoma, this is actually more commonly seen in primary Sjogren's syndrome. Primary Sjogren’s syndrome, which occurs without an associated autoimmune disease, has a notably higher risk of lymphoma (particularly mucosa-associated lymphoid tissue (MALT) lymphoma). The risk is less pronounced in secondary Sjogren’s syndrome, where it typically occurs alongside other autoimmune diseases (such as rheumatoid arthritis or systemic lupus erythematosus). Therefore, secondary Sjogren's syndrome is not as strongly linked to lymphoma risk compared to primary Sjogren’s syndrome. Why the Other Options Are Correct: A) Primary Sjogren’s is associated with increased risk of systemic manifestations: Primary Sjogren's syndrome is indeed associated with a higher risk of systemic manifestations. These can include renal involvement, neurological symptoms, and vasculitis. It can also lead to pulmonary manifestations, such as interstitial lung disease. As a result, primary Sjogren's often has a more severe disease course with systemic involvement, compared to secondary Sjogren's, which is more confined to dryness of the eyes and mouth. C) Elderly onset of disease has poorer prognosis: Onset of Sjogren's syndrome in elderly individuals is associated with a poorer prognosis. Older age at onset of the disease is often linked to a more aggressive disease course, with a higher likelihood of systemic manifestations and complications. The risk of developing lymphoma, renal disease, or other severe complications increases with elderly onset, which contributes to the poorer overall prognosis. D) High SSA antibody titers are associated with increased risk of lymphoma: High titers of SSA antibodies (anti-Ro antibodies) are indeed associated with an increased risk of lymphoma, particularly in primary Sjogren’s syndrome. Elevated SSA antibody levels have been linked to an increased risk of developing B-cell lymphoma, including MALT lymphoma. This risk is notable in patients with primary Sjogren's and is a key area of concern in the long-term management of the disease.",
      "correct_choice_id": 234007,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/43691211698838876/43691211698838876.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/43691211698838876/43691211698838876.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62843,
      "choices": [
        {
          "id": 234010,
          "text": "Bilateral skin thickenening is the hallmark of the disease"
        },
        {
          "id": 234011,
          "text": "In established SSc, Mask-like face” with loss of wrinkles can appear."
        },
        {
          "id": 234012,
          "text": "Nailbed capilloroscopycan reveal distorted nailbed capillary with micro-hemorrhages"
        },
        {
          "id": 234013,
          "text": "Nailbed capillaroscopy cannot differentiate between primary and secondary Raynaud’s phenomenon."
        }
      ],
      "text": "Which of thefollowing statements about Systemic sclerosis istrue EXCEPT:",
      "unique_key": "Q2782493",
      "question_audio": null,
      "question_video": null,
      "map_id": 34822585,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Nailbed capillaroscopy cannot differentiate between primary and secondary Raynaud’s phenomenon. This statement is incorrect because nailbed capillaroscopy is a useful tool in differentiating between primary and secondary Raynaud’s phenomenon. In secondary Raynaud’s, particularly in systemic sclerosis (SSc), capillaroscopy often reveals abnormalities such as distorted capillaries, micro-hemorrhages, and giant loops. These findings are typical of secondary Raynaud's due to underlying connective tissue diseases like systemic sclerosis. In primary Raynaud's, the capillaries are typically more normal in appearance, showing fewer or no abnormalities. Therefore, capillaroscopy can be helpful in distinguishing primary from secondary Raynaud’s, making option D incorrect. Why the Other Options Are Correct: A) Bilateral skin thickening is the hallmark of the disease: Bilateral skin thickening is indeed a hallmark of systemic sclerosis (SSc), particularly in the diffuse form of the disease. This skin thickening commonly involves the proximal limbs, trunk, and face. As the disease progresses, the skin becomes more tight and rigid due to excessive collagen deposition. This bilateral and symmetrical skin involvement is a key feature of systemic sclerosis. B) In established SSc, \"mask-like face\" with loss of wrinkles can appear: A \"mask-like face\" with loss of wrinkles is a classic feature of systemic sclerosis as the disease progresses. This occurs due to the tightening and thickening of the skin, particularly on the face, which leads to the loss of facial expression and a smooth, mask-like appearance. The inability to form wrinkles, particularly around the eyes and mouth, is a distinguishing characteristic of established systemic sclerosis. C) Nailbed capillaroscopy can reveal distorted nailbed capillary with micro-hemorrhages: Nailbed capillaroscopy is indeed an essential diagnostic tool in systemic sclerosis (SSc) and can reveal distorted nailbed capillaries with micro-hemorrhages, which are indicative of secondary Raynaud's phenomenon. These findings are highly suggestive of systemic sclerosis, helping to differentiate it from other conditions. The capillaries in SSc are often dilated, disorganized, and may show micro-hemorrhages or giant loops, which are not typically seen in healthy individuals or in primary Raynaud's phenomenon.",
      "correct_choice_id": 234013,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/27248881698838936/27248881698838936.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/27248881698838936/27248881698838936.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62844,
      "choices": [
        {
          "id": 234014,
          "text": "Antinuclear antibody"
        },
        {
          "id": 234015,
          "text": "Anti-SSA (Ro)"
        },
        {
          "id": 234016,
          "text": "Anti-SSB (La)"
        },
        {
          "id": 234017,
          "text": "RA Factor"
        }
      ],
      "text": "A 50-year-old woman comes to OPD with several months of increasing dryness of her mouth and eyes. Her eyes are “burning” and “itching” and sometimes feels like she has a grain of sand in them. She feels like she has “dry cotton” in her mouth. She has joint pain in her knees and ankles. Past medical history-Primary biliary cirrhosis and Hypothyroidism. On throat examination-several lost teeth and dental caries present. Which test is most likely to be positive in this patient?",
      "unique_key": "Q7348116",
      "question_audio": null,
      "question_video": null,
      "map_id": 34822408,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Antinuclear Antibody (ANA) This patient has secondary Sjögren’s syndrome (also called secondary Sicca syndrome) due to underlying autoimmune conditions—primary biliary cirrhosis and hypothyroidism. In secondary Sjögren’s, the most likely antibody to be positive is ANA, with positivity rates around 90%. Although ANA is nonspecific, it is the most frequently positive autoantibody in secondary Sjögren’s, making it the correct answer based on the phrasing of the question: \"Which test is most likely to be positive?\" Incorrect Options and Why They Are Incorrect: B. Anti-SSA (Ro): Although Anti-SSA (Ro) is more specific to Sjögren’s syndrome, it is less frequently positive in secondary Sjögren’s (seen in ~40–60% of cases). The question asked for the most likely positive test, not the most specific—so ANA, which has a higher positivity rate, is the better choice. C. Anti-SSB (La): Anti-SSB is even less sensitive than Anti-SSA and is typically positive in only 15–30% of secondary Sjögren’s cases. Therefore, it is less likely to be positive than ANA or Anti-SSA. D. Rheumatoid Factor (RF): RF can be positive in Sjögren’s syndrome (especially if associated with rheumatoid arthritis), but it is nonspecific and less frequently positive than ANA in patients with secondary Sjögren’s. It may support the diagnosis, but it is not the most likely to be positive.",
      "correct_choice_id": 234014,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46534111698839956/46534111698839956.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46534111698839956/46534111698839956.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62845,
      "choices": [
        {
          "id": 234018,
          "text": "Loss of amylase and lipase"
        },
        {
          "id": 234019,
          "text": "Loss of salivary protease"
        },
        {
          "id": 234020,
          "text": "Increased lysozyme"
        },
        {
          "id": 234021,
          "text": "Increased lactoperoxidase"
        }
      ],
      "text": "A 40 year old female patient presented with dry mouth and dry eye sensation. On lab test ANA and anti Ro ab are positive. Schirmer test is also abnormal. Oral examination shows dental caries. A diagnosis of Sjogren syndrome is made. She also complaints of impaired taste sensation. Which of these impairs taste perception in Sjögren syndrome?",
      "unique_key": "Q7848907",
      "question_audio": null,
      "question_video": null,
      "map_id": 34410434,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Loss of amylase and lipase. In Sjögren's syndrome, the salivary glands are primarily affected, leading to dry mouth (xerostomia) and reduced saliva production. The loss of saliva secretion in this condition can impair the oral environment and affect the sense of taste. Amylase and lipase are enzymes found in saliva, and they play important roles in breaking down carbohydrates and fats, respectively. When the production of these enzymes is reduced due to salivary gland dysfunction, it can alter the perception of taste. Specifically, the loss of amylase (which helps break down carbohydrates) and lipase (which helps digest lipids) can impair the proper functioning of the taste buds and contribute to the sensation of impaired taste. This explains the complaint of impaired taste sensation in the patient. Why the Other Options Are Incorrect: B) Loss of salivary protease: Salivary proteases (such as proteinases) are involved in the breakdown of proteins in the saliva, but they do not have a direct role in the perception of taste. While proteases contribute to the digestion of food, their loss in Sjögren's syndrome is unlikely to be the primary cause of impaired taste. Amylase and lipase are more relevant to taste perception, as they help process food molecules that stimulate taste receptors. C) Increased lysozyme: Lysozyme is an enzyme present in saliva, which helps protect against bacterial infections by breaking down bacterial cell walls. While lysozyme levels might be altered in Sjögren's syndrome, its increase is not directly associated with impaired taste perception. The impairment in taste sensation is more likely due to the loss of enzymes like amylase and lipase, which play a more direct role in food digestion and taste. D) Increased lactoperoxidase: Lactoperoxidase is another enzyme in saliva with antimicrobial properties, helping to protect the mouth from infections. Increased lactoperoxidase is not linked to the impairment of taste sensation in Sjögren's syndrome. Just as with lysozyme, while it plays a role in oral health, it does not directly affect the perception of taste.",
      "correct_choice_id": 234018,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/11763471698839980/11763471698839980.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/11763471698839980/11763471698839980.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62846,
      "choices": [
        {
          "id": 234022,
          "text": "Anti-Jo"
        },
        {
          "id": 234023,
          "text": "Anti-centromere antibody"
        },
        {
          "id": 234024,
          "text": "ANA"
        },
        {
          "id": 234025,
          "text": "Antineutrophil cytoplasmic autoantibody (ANCA)"
        }
      ],
      "text": "A 44-year-old woman with progressive immobility of her fingers and tightening of her face. She also complains of shortness of breath. Past medical history-Hypertension and Raynaud disease. She is taking nifedipine. On examination-BP-160/100 mmHg, Chest: fine crepitations present, Extremities: sclerodactyly, edema of lower extremities, Skin: tightening at face and hand and telangiectasia present. Which of the following tests is most likely to be positive?",
      "unique_key": "Q6993560",
      "question_audio": null,
      "question_video": null,
      "map_id": 34990848,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) ANA (Antinuclear Antibody). The patient is presenting with symptoms indicative of Systemic Sclerosis (Scleroderma), which is a connective tissue disorder characterized by skin tightening, Raynaud's phenomenon, sclerodactyly, and pulmonary involvement (e.g., fine crepitations). The presence of Raynaud's disease, hypertension, sclerodactyly, and telangiectasia all point towards a diagnosis of Systemic Sclerosis. The most common autoantibody in Systemic Sclerosis is the antinuclear antibody (ANA), which is often positive in these patients. ANA positivity is seen in the majority of Systemic Sclerosis cases and is a critical part of the diagnostic workup. While ANA is not specific to Systemic Sclerosis, its presence in the setting of the patient's clinical findings makes it the most likely test to be positive in this case. Why the Other Options Are Incorrect: A) Anti-Jo: Anti-Jo-1 antibodies are associated with polymyositis and dermatomyositis, particularly with interstitial lung disease. These conditions are characterized by muscle weakness and skin rashes, which are not the primary features in this patient's case. The patient's symptoms are more consistent with Systemic Sclerosis than with myositis. B) Anti-centromere antibody: Anti-centromere antibodies are more commonly seen in a subset of patients with limited cutaneous systemic sclerosis (formerly known as CREST syndrome). While this patient does have features such as Raynaud's disease and telangiectasia, the presence of more widespread skin tightening and pulmonary involvement (e.g., crepitations) suggests a diffuse form of Systemic Sclerosis, where ANA is more commonly positive than anti-centromere antibodies. D) Antineutrophil cytoplasmic autoantibody (ANCA): ANCA is associated with vasculitis, including conditions such as granulomatosis with polyangiitis (formerly Wegener's granulomatosis), and is not typically positive in Systemic Sclerosis. This patient's presentation does not fit with the characteristic signs of vasculitis, making ANCA less likely to be positive in this case.",
      "correct_choice_id": 234024,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/19569931698840052/19569931698840052.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/19569931698840052/19569931698840052.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62847,
      "choices": [
        {
          "id": 234026,
          "text": "Calcinosis and sclerodactyly"
        },
        {
          "id": 234027,
          "text": "Pulmonary fibrosis"
        },
        {
          "id": 234028,
          "text": "Renal fibrosis"
        },
        {
          "id": 234029,
          "text": "Cardiac fibrosis"
        }
      ],
      "text": "In continuation with previous clinical vignette patient underwent investigations and reports showed: SCL-70: positive, ANA: positive, Chest x-ray: normal, Oximeter: 96% saturation on room air, CBC: normal. Which manifestation of scleroderma can be slowed with treatment?",
      "unique_key": "Q3992943",
      "question_audio": null,
      "question_video": null,
      "map_id": 34520920,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Pulmonary fibrosis. The patient's diagnosis of Systemic Sclerosis (Scleroderma) is confirmed by positive SCL-70 and ANA tests, which indicate the diffuse cutaneous form of scleroderma. Pulmonary fibrosis is a significant complication of Systemic Sclerosis and is one of the leading causes of morbidity and mortality in these patients. While pulmonary fibrosis is a progressive disease, it can be slowed with treatment. Disease-modifying antirheumatic drugs (DMARDs), such as methotrexate, and immunosuppressive agents like mycophenolate mofetil or cyclophosphamide, can help control the inflammatory process and slow down the progression of pulmonary fibrosis. Additionally, pirfenidone and nintedanib, specific treatments for pulmonary fibrosis, have shown effectiveness in slowing down disease progression. Thus, treatment aimed at controlling pulmonary fibrosis can improve quality of life and reduce complications in patients with Systemic Sclerosis. Why the Other Options Are Incorrect: A) Calcinosis and sclerodactyly: Calcinosis (the deposition of calcium in the skin and soft tissues) and sclerodactyly (tightening of the skin around the fingers) are characteristic features of Systemic Sclerosis, but they do not respond well to treatment. These manifestations are more related to the progressive fibrosis of skin and soft tissues, and while therapies like vasodilators or immunosuppressants may provide some symptomatic relief, they are not as responsive to treatment as pulmonary fibrosis. C) Renal fibrosis: Renal fibrosis in Systemic Sclerosis can lead to scleroderma renal crisis, which presents with acute renal failure and hypertension. This complication requires aggressive management, often with ACE inhibitors to control blood pressure and prevent renal damage. However, once significant renal fibrosis occurs, it is less likely to be reversed or slowed by treatment compared to pulmonary fibrosis. D) Cardiac fibrosis: Cardiac involvement in Systemic Sclerosis, especially cardiac fibrosis, can lead to arrhythmias, heart failure, and other complications. However, like renal fibrosis, cardiac fibrosis is generally not as amenable to treatment as pulmonary fibrosis. Treatments may help manage symptoms, but slowing the progression of cardiac fibrosis is challenging, and no specific therapies are proven to significantly alter its course.",
      "correct_choice_id": 234027,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/71247861698840086/71247861698840086.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/71247861698840086/71247861698840086.m3u8",
      "question_images": [],
      "explanation_images": []
    }
  ]
}